Adaptive Biotechnologies COO Julie Rubinstein's stock transactions announced.

Adaptive Biotechnologies Corporation has recently disclosed various transactions involving its President and Chief Operating Officer, Julie Rubinstein. On March 30, 2026, Rubinstein sold 19,060 shares at a price of $12.63 per share and subsequently purchased 14,722 shares at $7.27 per share on the following day. Furthermore, on March 31, 2026, she sold an additional 19,060 shares at $13.45 per share and bought 14,722 shares at $7.27 per share on March 30, 2026. Additionally, Rubinstein sold 2,738 shares at $12.49 per share on March 27, 2026, and sold 16,322 shares at $13.48 per share on the same day. However, she purchased 14,722 shares at $7.27 per share on March 27, 2026. These transactions reflect the ongoing management of the company's equity by its President and Chief Operating Officer.